DNTH - Dianthus Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$111.91
DETAILS
HIGH:
$145.00
LOW:
$55.00
MEDIAN:
$120.00
CONSENSUS:
$111.91
UPSIDE:
29.41%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 2.0 | 6.2 | 2.8 | 6.4 | 1.5 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 2.0 | 1.8 | 0.9 | 0.4 | 0.0 |
| Gross Profit | 2.0 | 6.2 | 2.8 | 6.4 | 1.5 | (2.0) | (1.8) | (0.9) | (0.4) | (0.0) |
| Operating Expenses | ||||||||||
| R&D Expenses | 145.6 | 83.1 | 32.8 | 29.4 | 12.6 | 48.6 | 57.4 | 41.3 | 27.9 | 5.8 |
| SG&A Expenses | 34.3 | 25.0 | 18.2 | 6.7 | 2.0 | 28.1 | 23.8 | 17.7 | 7.5 | 3.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 180.0 | 108.1 | 51 | 36.1 | 14.6 | 76.7 | 81.1 | 59.1 | 35.4 | 9.3 |
| Operating Income | ||||||||||
| Operating Income | (177.9) | (101.9) | (48.2) | (29.7) | (13.1) | (78.7) | (83.0) | (60.0) | (35.7) | (9.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 3.8 | 0 | 0 | 0 | 0.2 |
| Interest Income | 16.1 | 17.4 | 4.8 | 1.1 | 0.1 | 3.8 | 0 | 2.4 | 0.2 | 0 |
| Profitability | ||||||||||
| EBITDA | (177.9) | (101.5) | (47.8) | (29.6) | (13.1) | (73.0) | (74.9) | (56.6) | (35.1) | (9.3) |
| EBIT | (177.9) | (101.9) | (48.2) | (29.7) | (13.1) | (74.9) | (76.8) | (57.5) | (35.5) | (9.3) |
| Income Before Tax | (162.3) | (85.0) | (43.6) | (28.5) | (13.1) | (74.9) | (76.8) | (57.5) | (35.5) | (9.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 |
| Net Income | (162.3) | (85.0) | (43.6) | (28.5) | (13.1) | (74.9) | (76.8) | (57.5) | (35.5) | (9.4) |
| Per Share Data | ||||||||||
| EPS (Basic) | -4.20 | -2.55 | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 | -16.05 | -4.27 |
| EPS (Diluted) | -4.20 | -2.55 | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 | -16.05 | -4.27 |
| Shares Outstanding | 37.8 | 33.3 | 5.2 | 3.7 | 3.4 | 2.7 | 2.3 | 2.1 | 2.2 | 2.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 51.1 | 22.8 | 132.3 | 15.4 | 131.7 | 58.2 | 65.1 | 58.3 | 51.6 | 4.5 |
| Short-Term Investments | 353.2 | 252.4 | 41.4 | 60.1 | 45.3 | 90.7 | 80.7 | 84.2 | 0 | 0 |
| Net Receivables | 0.1 | 0.8 | 0.5 | 5.6 | 0 | 0 | 0 | 0 | 0 | 6.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.0 | 0.4 | 0.5 | 0.1 | 3.8 | 2.7 | 4.1 | 2.8 | 0.9 | 0.0 |
| Total Current Assets | 409.4 | 280.9 | 177.5 | 82.0 | 180.7 | 151.5 | 149.8 | 145.3 | 52.5 | 10.8 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 1.6 | 1.7 | 0.8 | 1.0 | 7.5 | 8.3 | 9.9 | 3.1 | 1.7 | 0.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 110.1 | 81.7 | 0 | 0 | 1.8 | 1.8 | 1.8 | 8.9 | 0.2 | 0 |
| Other Non-Current Assets | 9.7 | 9.6 | 1.2 | 0.1 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Total Non-Current Assets | 121.5 | 93.1 | 2.0 | 1.1 | 9.2 | 10.1 | 11.7 | 12.0 | 2.0 | 0.5 |
| Total Assets | 530.9 | 374.0 | 179.4 | 83.1 | 189.9 | 161.6 | 161.5 | 157.3 | 54.5 | 11.3 |
| Current Liabilities | ||||||||||
| Account Payables | 9.7 | 4.6 | 2.6 | 1.2 | 3.0 | 3.8 | 2.8 | 3.5 | 0.2 | 1.7 |
| Short-Term Debt | 0.4 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.2 | 0.5 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 19.5 | 13.1 | 5.4 | 2.1 | 4.5 | 4.6 | 8.1 | 4.4 | 2.6 | 0.1 |
| Total Current Liabilities | 30.7 | 18.5 | 9.6 | 8.2 | 10.9 | 11.4 | 14.1 | 10.4 | 4.1 | 2.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 6.4 | 6.3 | 6.2 | 1.2 | 0 | 0 |
| Total Non-Current Liabilities | 6.8 | 3.1 | 0.9 | 1.2 | 6.4 | 6.3 | 6.2 | 1.2 | 0 | 0 |
| Total Liabilities | 37.5 | 21.5 | 10.5 | 9.5 | 17.3 | 17.7 | 20.3 | 11.7 | 4.1 | 2.3 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (336.7) | (174.4) | (89.4) | (45.9) | (325.6) | (254.4) | (179.5) | (102.7) | (45.2) | (9.7) |
| Accumulated Other Comprehensive Income | 0.5 | 0.1 | 0.0 | (0.2) | (0.0) | (0.0) | 0.0 | (0.0) | (0.4) | (0.0) |
| Total Stockholders' Equity | 493.4 | 352.5 | 168.9 | 73.7 | 172.7 | 143.9 | 141.2 | 145.6 | 50.3 | 9.0 |
| Total Liabilities & Equity | 530.9 | 374.0 | 179.4 | 83.1 | 189.9 | 161.6 | 161.5 | 157.3 | 54.5 | 11.3 |
| Debt Metrics | ||||||||||
| Total Debt | 1.4 | 1.5 | 0.6 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (49.7) | (21.3) | (131.7) | (14.6) | (131.7) | (58.2) | (65.1) | (58.3) | (51.6) | (4.5) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (162.3) | (85.0) | (43.6) | (28.5) | (71.1) | (74.9) | (76.8) | (57.5) | (35.5) | (9.4) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.4 | 0.1 | 2.0 | 2.0 | 1.8 | 0.9 | 0.4 | 0.0 |
| Stock-Based Compensation | 22.8 | 12.9 | 2.9 | 1.5 | 0 | 0 | 0 | 0 | 2.3 | 0.7 |
| Change in Working Capital | 16.7 | (0.4) | 4.9 | (1.7) | (1.5) | (1.2) | 8.8 | 4.0 | 1.3 | 1.6 |
| Other Non-Cash Items | (6.7) | (6.2) | (0.8) | (0.6) | 11.1 | 23.1 | 22.5 | 10.0 | 13.4 | 0.3 |
| Operating Cash Flow | (129.1) | (78.2) | (36.9) | (29.1) | (59.5) | (64.0) | (57.1) | (41.9) | (22.3) | (6.5) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.2) | (0.1) | (0.1) | (0.1) | (1.3) | (0.4) | (3.1) | (7.7) | (2.2) | (0.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 |
| Purchases of Investments | (435.0) | (413.7) | (57.4) | (61.7) | (45.3) | (95.7) | (144.4) | (84.0) | 0 | 0 |
| Sales/Maturities of Investments | 312.4 | 127 | 77.8 | 2 | 90 | 85.5 | 149.0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | (0.1) | 0 |
| Investing Cash Flow | (122.8) | (286.8) | 20.3 | (59.8) | 43.4 | (10.6) | 1.5 | (91.7) | (2.2) | (0.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.5 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.2) | (0.1) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (13.6) | 61.6 | (3.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 280.1 | 255.6 | 133.6 | 96.7 | 89.6 | 67.7 | 62.3 | 142.1 | 71.5 | 10.7 |
| Cash Position | ||||||||||
| Net Change in Cash | 28.2 | (109.4) | 117.0 | 7.8 | 73.5 | (6.9) | 6.7 | 6.8 | 47.0 | 4.0 |
| Cash at Beginning | 23.0 | 132.4 | 15.4 | 7.6 | 58.2 | 65.1 | 58.3 | 51.6 | 4.5 | 0.5 |
| Cash at End | 51.3 | 23.0 | 132.4 | 15.4 | 131.7 | 58.2 | 65.1 | 58.3 | 51.6 | 4.5 |
| Free Cash Flow | (129.3) | (78.3) | (37.0) | (29.2) | (60.8) | (64.4) | (60.2) | (49.6) | (24.5) | (6.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.0 | 6.2 | 2.8 | 6.4 | 1.5 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 2.0 | 6.2 | 2.8 | 6.4 | 1.5 | (2.0) | (1.8) | (0.9) | (0.4) | (0.0) |
| Operating Income | (177.9) | (101.9) | (48.2) | (29.7) | (13.1) | (78.7) | (83.0) | (60.0) | (35.7) | (9.3) |
| Net Income | (162.3) | (85.0) | (43.6) | (28.5) | (13.1) | (74.9) | (76.8) | (57.5) | (35.5) | (9.4) |
| EPS (Diluted) | -4.20 | -2.55 | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 | -16.05 | -4.27 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 51.1 | 22.8 | 132.3 | 15.4 | 131.7 | 58.2 | 65.1 | 58.3 | 51.6 | 4.5 |
| Total Assets | 530.9 | 374.0 | 179.4 | 83.1 | 189.9 | 161.6 | 161.5 | 157.3 | 54.5 | 11.3 |
| Total Debt | 1.4 | 1.5 | 0.6 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stockholders' Equity | 493.4 | 352.5 | 168.9 | 73.7 | 172.7 | 143.9 | 141.2 | 145.6 | 50.3 | 9.0 |
| Cash Flow | ||||||||||
| Operating Cash Flow | (129.1) | (78.2) | (36.9) | (29.1) | (59.5) | (64.0) | (57.1) | (41.9) | (22.3) | (6.5) |
| Capital Expenditure | (0.2) | (0.1) | (0.1) | (0.1) | (1.3) | (0.4) | (3.1) | (7.7) | (2.2) | (0.1) |
| Free Cash Flow | (129.3) | (78.3) | (37.0) | (29.2) | (60.8) | (64.4) | (60.2) | (49.6) | (24.5) | (6.7) |